Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429712 · ClinicalTrials.gov registry record · NA
Patient- and Task-specific Radiation Dose Optimization for Pediatric Abdominopelvic CT Applications
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03429712 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 19 participants.
The verdict
NCT03429712, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Radiation dose reduction has been a primary driver of technology development in multi-detector computed tomography (MDCT). The optimization of radiation dose for patient and task specific computed tomography (CT) applications continues to be an ongoing challenge, especially in pediatric patients where the desire to reduce radiation dose to lowest possible levels leads to both positive and negative effects. A novel research tool on the Siemens dual source (Flash® and Force ®) CT scanners allows one to assess multiple tube current levels from a single CT acquisition without incurring additional dose to the patient. Tube current is a primary contributor to radiation dose and image noise, which are inversely related. This is achieved by independently adjusting the current of each tube, while maintaining same kV in each x-ray tube. Moreover, Duke's medical physics team has developed a method based on mathematical expressions that allows the creation of incremental dose levels from the acquired image data sets. This innovative and powerful tool can be used to compare diagnostic accuracy, detectability, and many more relevant clinical features amongst multiple tube current levels with the attainment of a single CT acquisition.
Interventions
- DEVICE Dual-source multi-detector computed tomography (DSSE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-09-15 |
| Est. Completion | 2019-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03429712
The ClinicalTrials.gov registry entry for NCT03429712 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dual-source multi-detector computed tomography (DSSE) is the first listed.
NCT03429712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03429712 about?
NCT03429712 is a clinical study titled "Patient- and Task-specific Radiation Dose Optimization for Pediatric Abdominopelvic CT Applications". Radiation dose reduction has been a primary driver of technology development in multi-detector computed tomography (MDCT). The optimization of radiation dose for patient and task specific computed tomography (CT) applications continues to be an ongoing challenge, especially in pediatric patients whe...
What is the current status of trial NCT03429712?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2018-09-15. Estimated completion is 2019-04-12.
What interventions are being tested in trial NCT03429712?
The interventions under investigation include: Dual-source multi-detector computed tomography (DSSE) (DEVICE).
Who is sponsoring clinical trial NCT03429712?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.